Your Organization NameRetrieving contract details... Hang tight!
Effective Date
Sep 29, 2024
Expiration Date
Sep 28, 2029
| Description | Buyer | Seller | Issued Date | Quantity | Unit Price | Annual Fee |
|---|---|---|---|---|---|---|
| Office of Acquisition Managementt Policy | Duke University | Sep 29, 2024 | 1 |
Office of Acquisition Managementt Policy
EMORY UNIVERSITY- FLUVID, A DRY POWDER, INHALED, MRNA-BASED TREATMENT FOR INFLUENZA AND COVID
Office of Acquisition Managementt Policy
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEVELOP AND COMMERCIALIZE A RAPID PHENOTYPIC ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) SYSTEM THAT WILL DELIVER RESULTS FOR DEFINITIVE THERAPEUTIC DECISIONS WITHIN 4 TO 6 HOURS FROM COLONIES ON A CULTURE
Office of Acquisition Managementt Policy
CURIEDX - RESEARCH AND DEVELOPMENT FOR AOI #17 - TRANSFORMING RESPIRATORY INFECTION SURVEILLANCE WITH COMPUTER VISION ON A SMARTPHONE